Diamedica Therapeutics Inc (DMAC)

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	2.08%8.15	7.99	6.70	6.44	5.82
Research and Development	2.08%8.15	7.99	6.70	6.44	5.82
Operating Income/Loss	0.15%-10.50	-10.48	-9.21	-9.03	-8.01
Income/Loss From Continuing Operations Before Tax	0.97%-10.13	-10.04	-8.73	-8.61	-7.69
Income Tax Expense/Benefit	0.01	0.01	0.01	0.01	0.01
	0.97%-10.14	-10.04	-8.74	-8.62	-7.70
Attributable To Parent	0.97%-10.14	-10.04	-8.74	-8.62	-7.70
Basic Average Shares	0.19%53.89	53.79	-	49.63	42.96
Basic Earnings Per Share	-0.19	-0.19	-	-0.17	-0.18